Eagle Asset Management Inc Sarepta Therapeutics, Inc. Transaction History

Eagle Asset Management Inc

$16.7 Billion
Q3 2024

A detailed history of Eagle Asset Management Inc transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Eagle Asset Management Inc holds 371,435 shares of SRPT stock, worth $14.7 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

371,435

Previous 406,046 8.52%

Holding current value

$14.7 Million

Previous $64.2 Million 27.69%

% of portfolio

0.28%

Previous 0.35%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$124.33 - $156.75 $4.3 Million - $5.43 Million	-34,611 Reduced 8.52%	371,435 $46.4 Million
Q2 2024 Aug 12, 2024	BUY	$113.33 - $163.85 $21.8 Million - $31.6 Million	192,617 Added 90.25%	406,046 $64.2 Million
Q1 2024 May 09, 2024	SELL	$93.7 - $141.53 $256,644 - $387,650	-2,739 Reduced 1.27%	213,429 $27.6 Million
Q4 2023 Feb 12, 2024	SELL	$67.31 - $124.76 $138,254 - $256,257	-2,054 Reduced 0.94%	216,168 $20.8 Million
Q3 2023 Nov 13, 2023	BUY	$102.5 - $123.59 $34,952 - $42,144	341 Added 0.16%	218,222 $26.5 Million
Q2 2023 Aug 09, 2023	SELL	$106.4 - $157.19 $354,737 - $524,071	-3,334 Reduced 1.51%	217,881 $25 Million
Q1 2023 May 08, 2023	BUY	$117.53 - $155.99 $26 Million - $34.5 Million	221,215 New	221,215 $30.5 Million
Q1 2021 May 14, 2021	SELL	$72.25 - $168.95 $22.8 Million - $53.4 Million	-316,248 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$125.56 - $178.74 $3.22 Million - $4.58 Million	-25,629 Reduced 7.5%	316,248 $53.9 Million
Q3 2020 Nov 12, 2020	SELL	$127.12 - $172.34 $12.7 Million - $17.3 Million	-100,115 Reduced 22.65%	341,877 $48.3 Million
Q2 2020 Aug 12, 2020	BUY	$93.0 - $171.7 $147,126 - $271,629	1,582 Added 0.36%	441,992 $71.9 Million
Q1 2020 May 11, 2020	SELL	$82.38 - $131.64 $250,517 - $400,317	-3,041 Reduced 0.69%	440,410 $43.1 Million
Q4 2019 Feb 07, 2020	BUY	$76.53 - $135.58 $623,796 - $1.11 Million	8,151 Added 1.87%	443,451 $57.2 Million
Q3 2019 Nov 04, 2019	SELL	$72.81 - $156.91 $20.9 Million - $45 Million	-286,588 Reduced 39.7%	435,300 $32.8 Million
Q2 2019 Aug 05, 2019	SELL	$112.21 - $151.95 $21.5 Million - $29.1 Million	-191,634 Reduced 20.98%	721,888 $110 Million
Q1 2019 May 01, 2019	SELL	$106.67 - $151.68 $18.7 Million - $26.5 Million	-175,034 Reduced 16.08%	913,522 $109 Million
Q4 2018 Feb 11, 2019	BUY	$97.32 - $148.76 $2.07 Million - $3.16 Million	21,238 Added 1.99%	1,088,556 $119 Million
Q3 2018 Nov 08, 2018	BUY	$115.31 - $161.51 $43.7 Million - $61.2 Million	379,162 Added 55.1%	1,067,318 $172 Million
Q2 2018 Aug 07, 2018	SELL	$71.74 - $153.69 $20.9 Million - $44.8 Million	-291,385 Reduced 29.75%	688,156 $91 Million
Q1 2018 May 09, 2018	SELL	$54.02 - $82.27 $391,212 - $595,799	-7,242 Reduced 0.73%	979,541 $72.6 Million
Q4 2017 Feb 09, 2018	SELL	$47.64 - $56.75 $926,073 - $1.1 Million	-19,439 Reduced 1.93%	986,783 $55.2 Million
Q3 2017 Nov 09, 2017	BUY	$35.73 - $47.15 $36 Million - $47.4 Million	1,006,222	1,006,222 $49.9 Million

Others Institutions Holding SRPT

# of Institutions

508

Shares Held

88.9M

Call Options Held

1.39M

Put Options Held

1.13M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $3.48B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.

Account

Eagle Asset Management Inc Sarepta Therapeutics, Inc. Transaction History